News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EMD Chemicals Inc. (MRK) Expands Multi-Analyte Portfolio Via Collaboration with MitoScience LLC to Develop and Distribute Assays for Drug Toxicity and Mitochondrial Bioactivity



10/23/2009 9:36:23 AM

GIBBSTOWN, N.J.--(BUSINESS WIRE)--EMD Chemicals Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, a leading supplier of assays, reagents, and chemicals for the life science and drug discovery market, announced today a research and commercial collaboration with MitoSciences Inc., a leading developer of antibodies and immunoassays for measuring mitochondrial and metabolic function, whose products are used by basic researchers, drug developers and clinicians.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES